63323-981-53 |
63323-981 |
HUMAN PRESCRIPTION DRUG |
Piperacillin and Tazobactam |
Piperacillin and Tazobactam |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRAVENOUS |
20180518 |
N/A |
ANDA |
ANDA203719 |
Fresenius Kabi USA, LLC |
PIPERACILLIN SODIUM; TAZOBACTAM SODIUM |
2 g/10mL; .25 g/10mL |
10 VIAL, SINGLE-USE in 1 CARTON (63323-981-53) / 10 mL in 1 VIAL, SINGLE-USE (63323-981-41) |
63323-983-21 |
63323-983 |
HUMAN PRESCRIPTION DRUG |
Piperacillin and Tazobactam |
Piperacillin and Tazobactam |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRAVENOUS |
20180518 |
N/A |
ANDA |
ANDA203719 |
Fresenius Kabi USA, LLC |
PIPERACILLIN SODIUM; TAZOBACTAM SODIUM |
3 g/15mL; .375 g/15mL |
10 VIAL, SINGLE-USE in 1 CARTON (63323-983-21) / 15 mL in 1 VIAL, SINGLE-USE (63323-983-23) |
65219-436-20 |
65219-436 |
HUMAN PRESCRIPTION DRUG |
Piperacillin and Tazobactam |
Piperacillin and Tazobactam |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRAVENOUS |
20230320 |
N/A |
ANDA |
ANDA203719 |
Fresenius Kabi USA, LLC |
PIPERACILLIN SODIUM; TAZOBACTAM SODIUM |
3 g/15mL; .375 g/15mL |
10 VIAL, SINGLE-DOSE in 1 CARTON (65219-436-20) / 15 mL in 1 VIAL, SINGLE-DOSE (65219-436-02) |
63323-982-52 |
63323-982 |
HUMAN PRESCRIPTION DRUG |
Piperacillin and Tazobactam |
Piperacillin and Tazobactam |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRAVENOUS |
20180518 |
N/A |
ANDA |
ANDA203719 |
Fresenius Kabi USA, LLC |
PIPERACILLIN SODIUM; TAZOBACTAM SODIUM |
4 g/20mL; .5 g/20mL |
10 VIAL, SINGLE-USE in 1 CARTON (63323-982-52) / 20 mL in 1 VIAL, SINGLE-USE (63323-982-21) |
63323-983-53 |
63323-983 |
HUMAN PRESCRIPTION DRUG |
Piperacillin and Tazobactam |
Piperacillin and Tazobactam |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRAVENOUS |
20180518 |
N/A |
ANDA |
ANDA203719 |
Fresenius Kabi USA, LLC |
PIPERACILLIN SODIUM; TAZOBACTAM SODIUM |
3 g/15mL; .375 g/15mL |
10 VIAL, SINGLE-USE in 1 CARTON (63323-983-53) / 15 mL in 1 VIAL, SINGLE-USE (63323-983-41) |
65219-434-20 |
65219-434 |
HUMAN PRESCRIPTION DRUG |
Piperacillin and Tazobactam |
Piperacillin and Tazobactam |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRAVENOUS |
20230320 |
N/A |
ANDA |
ANDA203719 |
Fresenius Kabi USA, LLC |
PIPERACILLIN SODIUM; TAZOBACTAM SODIUM |
2 g/10mL; .25 g/10mL |
10 VIAL, SINGLE-DOSE in 1 CARTON (65219-434-20) / 10 mL in 1 VIAL, SINGLE-DOSE (65219-434-02) |
63323-982-54 |
63323-982 |
HUMAN PRESCRIPTION DRUG |
Piperacillin and Tazobactam |
Piperacillin and Tazobactam |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRAVENOUS |
20180518 |
N/A |
ANDA |
ANDA203719 |
Fresenius Kabi USA, LLC |
PIPERACILLIN SODIUM; TAZOBACTAM SODIUM |
4 g/20mL; .5 g/20mL |
10 VIAL, SINGLE-USE in 1 CARTON (63323-982-54) / 20 mL in 1 VIAL, SINGLE-USE (63323-982-43) |
65219-259-55 |
65219-259 |
HUMAN PRESCRIPTION DRUG |
Piperacillin and Tazobactam |
Piperacillin and Tazobactam |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRAVENOUS |
20210524 |
N/A |
ANDA |
ANDA203719 |
Fresenius Kabi USA, LLC |
PIPERACILLIN SODIUM; TAZOBACTAM SODIUM |
4 g/20mL; .5 g/20mL |
10 VIAL, SINGLE-USE in 1 CARTON (65219-259-55) / 20 mL in 1 VIAL, SINGLE-USE (65219-259-15) |
63323-981-21 |
63323-981 |
HUMAN PRESCRIPTION DRUG |
Piperacillin and Tazobactam |
Piperacillin and Tazobactam |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRAVENOUS |
20180518 |
N/A |
ANDA |
ANDA203719 |
Fresenius Kabi USA, LLC |
PIPERACILLIN SODIUM; TAZOBACTAM SODIUM |
2 g/10mL; .25 g/10mL |
10 VIAL, SINGLE-USE in 1 CARTON (63323-981-21) / 10 mL in 1 VIAL, SINGLE-USE (63323-981-23) |
65219-259-45 |
65219-259 |
HUMAN PRESCRIPTION DRUG |
Piperacillin and Tazobactam |
Piperacillin and Tazobactam |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRAVENOUS |
20180518 |
N/A |
ANDA |
ANDA203719 |
Fresenius Kabi USA, LLC |
PIPERACILLIN SODIUM; TAZOBACTAM SODIUM |
4 g/20mL; .5 g/20mL |
10 VIAL, SINGLE-USE in 1 CARTON (65219-259-45) / 20 mL in 1 VIAL, SINGLE-USE (65219-259-05) |